Clinical Outcomes and Prognostic Factors for R0 Resected Colorectal Cancer with Synchronous Peritoneal Metastasis: A Retrospective Study

被引:0
|
作者
Fukata, Koji [1 ]
Fukunaga, Yosuke [1 ]
Hiyoshi, Yukiharu [1 ]
Mukai, Toshiki [1 ]
Yamaguchi, Tomohiro [1 ]
Nagasaki, Toshiya [1 ]
Nagayama, Satoshi [1 ]
Akiyoshi, Takashi [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan
关键词
peritoneal metastasis; colorectal cancer; R0; resection; laparoscopy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PRIMARY TUMOR RESECTION; CYTOREDUCTIVE SURGERY; JAPANESE CLASSIFICATION; LAPAROSCOPIC SURGERY; PRODIGE; 7; CARCINOMATOSIS; PNEUMOPERITONEUM; DISSEMINATION; MULTICENTER;
D O I
10.23922/jarc.2023-071
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Peritoneal metastasis indicates a poor prognosis in patients with colorectal cancer (CRC). Studies have shown improved prognosis in patients after removal of peritoneal dissemination, and this surgery is recommended if not excessively invasive. The aim of this study was to examine clinical outcomes and prognostic factors for R0 resected CRC with synchronous peritoneal metastasis. Methods: We analyzed data retrospectively from 250 patients with stage IV CRC who underwent R0 resection at our hospital. The patients were divided into three groups according to the type of surgery: nonresected (N), palliative primary tumor resection (P), and R0 resection (R0) groups. Overall survival (OS) and recurrence-free survival (RFS) were investigated and clinicopathological parameters were analyzed for prognostic significance. Results: The 3-year OS was 57.2% in the R0 group. The R0 group had a significantly higher 3-year OS than that in the other groups (p < 0.0001). Multivariate analysis revealed that histological type, lymphatic and venous invasion, liver metastasis, R0 resection, and perioperative chemotherapy were independent prognostic factors. The 5-year RFS in the R0 group was 26.5%. Multivariate analysis revealed that the number of peritoneal metastases and surgical procedure were independent prognostic factors. Laparoscopic surgery had better 5-year RFS in the R0 group compared with that in the open surgery group (p = 0.0044). Conclusions: R0 resection of colorectal cancer with synchronous peritoneal metastasis should be considered for improving long-term survival. The laparoscopic approach for this disease is another promising method to prolong survival in patients with R0 resection.
引用
收藏
页码:365 / 374
页数:10
相关论文
共 50 条
  • [41] Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma
    Gold, Jason S.
    Tang, Laura H.
    Gonen, Mithat
    Coit, Daniel G.
    Brennan, Murray F.
    Allen, Peter J.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) : 3159 - 3167
  • [42] Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma
    Jason S. Gold
    Laura H. Tang
    Mithat Gönen
    Daniel G. Coit
    Murray F. Brennan
    Peter J. Allen
    Annals of Surgical Oncology, 2007, 14 : 3159 - 3167
  • [43] Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a population-based study
    Xiaofen Li
    Wangxiong Hu
    Hongna Sun
    Hongfeng Gou
    Clinical & Experimental Metastasis, 2021, 38 : 89 - 95
  • [44] Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a population-based study
    Li, Xiaofen
    Hu, Wangxiong
    Sun, Hongna
    Gou, Hongfeng
    CLINICAL & EXPERIMENTAL METASTASIS, 2021, 38 (01) : 89 - 95
  • [45] Prognostic factors of survival outcomes in colorectal cancer patients with liver metastasis
    Pimtip, Sanvarinda
    Somkit, Mingphruedhi
    Manmana, Jirajarus
    Prapai, Chengtawee
    Ekaphop, Sirachainan
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Retrospective evaluation of patients with colorectal cancer with metastasis in the central nervous system: Clinical and epidemiological prognostic factors
    Sa, D.
    Donadio, M.
    Cesca, M.
    Loose, S.
    Mello, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S168 - S168
  • [47] Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status)
    Koji Komori
    Takashi Kinoshita
    Taihei Oshiro
    Akira Ouchi
    Seiji Ito
    Tetsuya Abe
    Yoshiki Senda
    Kazunari Misawa
    Yuichi Ito
    Seiji Natsume
    Eiji Higaki
    Masataka Okuno
    Takahiro Hosoi
    Byonggu An
    Daisuke Hayashi
    Tairin Uchino
    Aina Kunitomo
    Satoshi Oki
    Jin Takano
    Yasuhito Suenaga
    Shingo Maeda
    Hideyuki Dei
    Yoshihisa Numata
    Yasuhiro Shimizu
    Surgery Today, 2019, 49 : 755 - 761
  • [48] Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status)
    Komori, Koji
    Kinoshita, Takashi
    Oshiro, Taihei
    Ouchi, Akira
    Ito, Seiji
    Abe, Tetsuya
    Senda, Yoshiki
    Misawa, Kazunari
    Ito, Yuichi
    Natsume, Seiji
    Higaki, Eiji
    Okuno, Masataka
    Hosoi, Takahiro
    An, Byonggu
    Hayashi, Daisuke
    Uchino, Tairin
    Kunitomo, Aina
    Oki, Satoshi
    Takano, Jin
    Suenaga, Yasuhito
    Maeda, Shingo
    Dei, Hideyuki
    Numata, Yoshihisa
    Shimizu, Yasuhiro
    SURGERY TODAY, 2019, 49 (09) : 755 - 761
  • [49] Prognostic Factors and Treatment Effects in Patients With Curatively Resected Brain Metastasis From Colorectal Cancer
    Suzuki, Yozo
    Yamaguchi, Tatsuro
    Matsumoto, Hiroshi
    Nakano, Daisuke
    Honda, Goro
    Shinoura, Nobusada
    Karasawa, Katsuyuki
    Takahashi, Keiichi
    DISEASES OF THE COLON & RECTUM, 2014, 57 (01) : 56 - 63
  • [50] Prognostic factors in patients who received surgery for colorectal cancer with peritoneal metastasis.
    Furutani, Akinobu
    Yamaguchi, Tomohiro
    Kinugasa, Yusuke
    Shiomi, Akio
    Kagawa, Hiroyasu
    Yamakawa, Yushi
    Manabe, Shoichi
    Yamaoka, Yusuke
    Ogi, Yusuke
    Nagasawa, Yoshinobu
    Hino, Hitoshi
    Kato, Shunichiro
    Suzuki, Takuya
    Torii, Kakeru
    Koido, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)